Psilocybin as a new way for depression treatment
Journal of Education Health and Sport – May 15, 2024
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen, shows significant promise in treating severe depression. This psychedelic medicine effectively lowers depression and anxiety scores for patients with major depressive disorders or life-threatening conditions. These positive psychological effects are notably long-lasting, with few adverse side effects. As a key area in Psychedelics and Drug Studies, this alkaloid compound offers a new avenue for psychiatry and medicine. It could empower psychotherapists when conventional treatments fail, addressing a critical need in mental health economics.
Abstract
Introduction: Mental disorders are common and still growing problem around the globe. Significantly decreasing quality of life, they are often source of true suffering for patients and their families leading to further health issues or even dramatic outcomes resulting in death. As public awareness rises, more and more people understand risks and tend to look for help as fast as possible. Currently available treatment methods are not always efficient enough to deal with more complex cases. Therefore it is important to look for new therapy options incrementing chances of fast and successful treatment. Results: Studies showed that psilocybin is not only able to lower depression and anxiety scores in patients with major depressive disorders or with serious life-threatening conditions but also proved this effect to be long-lasting. At the same time, no or little adverse side effects were noticed. Conclusions: Psilocybin is potentially a good method for depression treatment in some groups of patients. It should be considered if other, better known therapies show little or no effects.